Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Rhythmic Auditory Stimulation Therapy on Upper-Limb Movements, Function, and Quality of Life in Patients With Schizophrenia: Randomized Controlled Trials

NCT07086040 is registered in ClinicalTrials.gov with Shu-Mei Wang as lead sponsor.

NCT NCT07086040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07086040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Rhythmic Auditory Stimulation Therapy on Upper-Limb Movements, Function, and Quality of Life in Patients With Schizophrenia: Randomized Controlled Trials
Lead sponsor
Shu-Mei Wang
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
July 31, 2028
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia and schizoaffective disorder